Aslan Pharmaceuticals Ltd.

Aslan Pharmaceuticals Ltd.

Aslan Pharmaceuticals Ltd.

Overview
Date Founded

2010

Headquarters

83 Clemenceau Avenue, No. 12-03 UE Square, Singapore, 239920, SGP

Type of Company

Public

Employees (Worldwide)

56

Industries

Biotechnology
Pharmaceuticals

Company Description

Aslan Pharmaceuticals Ltd. is a clinical-stage oncology-focused biopharmaceutical company, which engages in the development of novel therapeutics. Its pipeline includes varlitinib, ASLAN003, ASLAN004, and ASLAN002. The firm's portfolio focuses on validated growth pathways applied to new patient segments, novel immune checkpoints, and novel cancer metabolic pathways. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale, and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Executives & Employees

Chief Executive Officer & Director

General Counsel

Chief Business Officer

Chief Development Officer, Head-R&D

Vice President, Finance

Board of Directors

Chief Financial Officer & Senior Vice President, Finance at Heron Therapeutics, Inc.

Chief Executive Officer & Director at Aslan Pharmaceuticals Ltd.

Founder at Cenova Ventures

Co-Founder & General Partner at BioVeda Capital Singapore (Pte) Ltd.

Independent Director at Aslan Pharmaceuticals Ltd.

General Manager at Hsin Pao Venture Capital Co. Ltd.

Paths to Aslan Pharmaceuticals Ltd.
Potential Connections via
Relationship Science
You
Aslan Pharmaceuticals Ltd.
Recent Transactions
Details Hidden

Aslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Transaction Advisors
Underwriter

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Underwriter

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Auditor

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Associate

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Associate

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Legal Advisor

Advised onAslan Pharmaceuticals Ltd. issued American Depositary Shares (ADS)

Advisors & Consultants
Legal Advisor

Partner at Davis Polk & Wardwell LLP

Clients

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

BioGenetics Co., Ltd. engages in the manufacture of rubber and latex products. It operates though the following business divisions: Condom, Cot, Glove and Plant. The condom business division provides differentiated condoms in thickness, design, and color at preferences. The cot business division offers white, yellow, and pink cots to protect detailed products from being polluted. The glove business division provides gloves used in hospital and in nuclear power plant. The company was founded on May 23, 1973 and is headquartered in Jeungpyeong-gun, South Korea.

Key Stats and Financials As of 2018
Market Capitalization
$1.01B
Total Enterprise Value
$3.24B
Earnings Per Share
$-8.49
Revenue
$0
Net Profit
$-1.27B
EBITDA
$-1.27B
Total Debt
$346M
Total Equity
$936M
TEVNet Income
-2.55x
Debt TEV
0.11x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Investors
Details Hidden

Goodman Capital invests in companies located in across Asia and USA. The frim provides financing for seed, early, later and Pre-IPO round. The firm invest in across the broad range of sectors tech, biotech and real estate.

Details Hidden

TaYa Venture Capital Co. Ltd. is an active manager which invests in Chinese firms. It provides financing from seed to later stage capital requirement. It focuses on technology and consumer sectors.

Details Hidden

XinChen Ventures is a private company headquartered in Taiwan that operates as private equity firm.

Suppliers
Merck KGaA Hospitals & Patient Services | Darmstadt, HE

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

CSL Limited Medical Support Services | Parkville, VIC

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.

Array BioPharma Inc. Hospitals & Patient Services | BOULDER, CO

Array BioPharma, Inc. engages in the research, development, and commercialization of targeted small molecule drugs for the treatment of cancer and other high-burden diseases. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.

Competitors
Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Agios Pharmaceuticals, Inc. Pharmaceuticals - Cambridge, Massachusetts

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Aslan Pharmaceuticals Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Aslan Pharmaceuticals Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Aslan Pharmaceuticals Ltd..